GATA-3-specific DNAzyme - A Novel Approach for Stratified Asthma Therapy

European Journal of Immunology - United Kingdom
doi 10.1002/eji.201646450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Novel Biomarkers for Asthma Stratification and Personalized Therapy

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2014English

Table 3: Postoperative Outcomes, Stratified by Operative Approach.

English

Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme

New England Journal of Medicine
Medicine
2015English

A Novel Approach to Glioma Therapy Using an Oncolytic Adenovirus With Two Specific Promoters

Oncology Letters
Cancer ResearchOncology
2017English

Th2 Cells and GATA-3 in Asthma: New Insights Into the Regulation of Airway Inflammation

Journal of Clinical Investigation
Medicine
1999English

Stratified Approach for Low Back Pain

PAIN RESEARCH
2017English

GATA-3 Dominant Negative Mutant

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

The K+channels KCa3.1 and Kv1.3 as Novel Targets for Asthma Therapy

British Journal of Pharmacology
Pharmacology
2009English

A Study of GATA-3 in Malignant Pleural Mesothelioma

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy